-
WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis
2026-09-11
The reference study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors (FAPs). By combining pharmacological inhibition, mass cytometry, transcriptomics, and in vivo muscle injury models, the authors show that GSK3 blockade and restored WNT5a signaling can suppress fat formation while enhancing FAP support of muscle satellite cell differentiation.
-
Rosemary Extract in Renal Amyloidosis: Mechanistic Evidence
2026-09-10
This study combines amyloid-fibril spectroscopy, MES13 cell experiments, and a mouse model to examine how rosemary ethanol extract may protect against renal amyloidosis. Its findings connect fibril remodeling with calcium and reactive oxygen species control, reduced PERK/ATF-4/CHOP signaling, lower apoptosis, and improved renal pathology.
-
Annexin V-FITC/7-AAD Apoptosis Kit Workflow
2026-09-10
Build a rapid, dual-parameter workflow for separating viable, early apoptotic, late apoptotic, and necrotic cells. Apply it to lactoferrin-processing studies, cell viability assays, and cytotoxicity comparisons while keeping membrane-based evidence distinct from pathway-level conclusions.
-
PBA-Modified PAD4 Inhibitors Block Tumor NETs
2026-09-09
This study developed phenylboronic acid (PBA)-modified PAD4 inhibitors to improve tumor localization and suppress the PAD4-H3cit-NETs pathway in neutrophils. Compound 5i reduced tumor growth and lung metastasis in mouse models while showing limited direct tumor-cell cytotoxicity, supporting a strategy based on tumor targeting and microenvironmental regulation.
-
Dabigatran: From Target Engagement to Assay Meaning
2026-09-09
Dabigatran and Pradaxa are more than direct thrombin inhibitors: they are tools for connecting molecular target engagement with clinically meaningful coagulation data. This evidence-aware guide shows how to interpret assay endpoints, metabolites, matrix effects, and safety implications without confusing laboratory potency with clinical performance.
-
Calcein AM/PI: Making Ferroptosis Translatable
2026-09-08
A mechanistic and translational framework for using Calcein AM/PI live/dead fluorescence to strengthen ferroptosis studies in mammalian cancer models.
-
Melatonin-Tuned LNPs Improve NRF2 mRNA MSC Therapy
2026-09-08
The reference study develops melatonin-tuned lipid nanoparticles that improve cytosolic delivery of Nrf2 mRNA and functionally enhance mesenchymal stem cells for pulmonary fibrosis therapy. Its central contribution is linking lipid membrane fluidity, endosomal escape, antioxidant MSC programming, and reduced fibrotic remodeling within one delivery strategy.
-
Porous Graphene MSI Maps Brain Lipid Asymmetry
2026-09-07
The reference study introduces laser-induced graphene as a matrix-free substrate for high-resolution laser desorption/ionization mass spectrometry imaging. Its application to ethanol-exposed mouse brains reveals time-dependent left–right asymmetry in nine lipid species, demonstrating how porous graphene can simplify MSI while preserving spatially resolved metabolic information.
-
Annexin V-PE Reagent: From Signal to Decision
2026-09-07
Annexin V-PE Reagent enables rapid phosphatidylserine externalization detection, but its greatest value comes from disciplined interpretation. This article connects Annexin V-based readouts with CD38 CAR-binder engineering, assay controls, and mechanism-aware cell death decisions.
-
LY294002 Workflows for PI3K Pathway Research
2026-09-05
LY294002 provides a reversible, cell-permeable approach for testing class I PI3K control of Akt/mTOR signaling, proliferation, apoptosis, and autophagosome formation. This practical guide connects dose-response experiments with cancer, ovarian carcinoma, and zebrafish angiogenesis workflows while highlighting off-target and cross-domain limitations.
-
Panobinostat and the RNF20/RNF40/WAC Axis in MLL-ALL
2026-09-04
This study demonstrates that panobinostat produces strong anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia in xenograft models and links that response to loss of H2B ubiquitination. Its combination of in vivo efficacy, molecular profiling, and WAC knockdown identifies the RNF20/RNF40/WAC-H2B pathway as a mechanistically relevant epigenetic vulnerability.
-
DAPI Workflows for Apoptosis and Nuclear Imaging
2026-09-04
Build reproducible DAPI assays for nuclear visualization, membrane-integrity screening, apoptosis-oriented imaging, and flow cytometry. This guide connects DAPI staining to the senescent nucleus pulposus cell–macrophage model and emphasizes controls, quantitative readouts, and troubleshooting.
-
Z-WEHD-FMK for Caspase-1 Pyroptosis Studies
2026-09-03
Z-WEHD-FMK provides a cell-permeable, irreversible way to test whether inflammatory caspases drive pyroptosis, pathogen-associated organelle remodeling, or related cell-death phenotypes. This workflow connects the HOXC8–CASP1 axis in lung cancer with practical controls for infection models, including timing, orthogonal readouts, and troubleshooting.
-
Parathyroid hormone (1-34) (human) Workflows
2026-09-03
Build reproducible cAMP, calcium-regulation, bone, and CKD-associated valvular calcification assays with a defined PTH1R-active peptide fragment. This guide connects concentration-controlled signaling experiments with the Foxp1–Notch–EndMT mechanism reported in a 2026 reference study.
-
Annexin V-FITC/7-AAD Apoptosis Kit Guide
2026-09-02
The Annexin V-FITC/7-AAD Apoptosis Kit supports rapid separation of viable, Annexin V-positive, and membrane-compromised cell populations for cell viability assays, cytotoxicity assays, and routine cell death analysis. It is suitable for flow cytometry or fluorescence microscopy, but the two-color readout should not be used alone to establish a molecular death pathway or distinguish every form of late apoptosis from primary necrosis.